Current perspectives with pemetrexed in thoracic malignancies

Chandra Belani

doi:10.3816/CLC.2004.s.001

Current perspectives with pemetrexed in thoracic malignancies

Chandra Belani

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	S45
Journal	Clinical Lung Cancer
Volume	5
Issue number	SUPPL. 2
DOIs	https://doi.org/10.3816/CLC.2004.s.001
State	Published - Apr 2004

All Science Journal Classification (ASJC) codes

Oncology
Pulmonary and Respiratory Medicine
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3816/CLC.2004.s.001

Cite this

@article{15fac4c13c034ddcb93690ad3eaece39,

title = "Current perspectives with pemetrexed in thoracic malignancies",

author = "Chandra Belani",

year = "2004",

month = apr,

doi = "10.3816/CLC.2004.s.001",

language = "English (US)",

volume = "5",

pages = "S45",

journal = "Clinical Lung Cancer",

issn = "1525-7304",

publisher = "Elsevier Inc.",

number = "SUPPL. 2",

}

TY - JOUR

T1 - Current perspectives with pemetrexed in thoracic malignancies

AU - Belani, Chandra

PY - 2004/4

Y1 - 2004/4

UR - http://www.scopus.com/inward/record.url?scp=2342658476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2342658476&partnerID=8YFLogxK

U2 - 10.3816/CLC.2004.s.001

DO - 10.3816/CLC.2004.s.001

M3 - Editorial

AN - SCOPUS:2342658476

SN - 1525-7304

VL - 5

SP - S45

JO - Clinical Lung Cancer

JF - Clinical Lung Cancer

IS - SUPPL. 2

ER -

Current perspectives with pemetrexed in thoracic malignancies

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this